| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |